HLTH 8451 Week 7 Health Outcome Valuation Critique Example

Public Policy Analysis (doctoral) Walden University Free custom sample in 24 to 48h

For a heat rule whose benefits are almost all deaths avoided among frail residents, this HLTH 8451 Week 7 health outcome valuation critique example shows that the valuation method can reverse the verdict: about $197 million in net benefits under an unadjusted value per statistical life, about $110 million in net losses when deaths are valued by remaining life-years. The paper explains where the statistical life value comes from, why its evidence base is mostly working-age adults, and how QALYs combine length and quality of life for cost-effectiveness. Separate sections examine the senior death discount controversy and the disability critique of QALYs. Walden HLTH 8451 asks students to choose, and this paper adopts the unadjusted value with QALYs reported beside it. The doctoral health administration program will see both used in the final analysis.

CourseHLTH 8451 Public Policy Analysis (doctoral)
WeekWeek 7
Paper typeCritique paper
LengthAbout 1,190 words, 7 pages
FormatAPA 7 student paper
SchoolWalden University
Programdoctoral health administration program
UpdatedOctober 2026

Free sample paper for HLTH 8451 Week 7

1

Twelve Million Dollars or Seven Hundred Thousand? Valuing Heat Deaths Avoided Among Frail Nursing Home Residents by Statistical Life and by Quality-Adjusted Life Year

Student Name

Walden University

HLTH 8451: Public Policy Analysis

Instructor Name

Month Day, Year

What this page is doingThe two figures in the title are the value of one death avoided under each method, which is why the choice decides the verdict.
2

Twelve Million Dollars or Seven Hundred Thousand? Valuing Heat Deaths Avoided Among Frail Nursing Home Residents by Statistical Life and by Quality-Adjusted Life Year

Why Valuation Decides This Rule

Nearly all the monetized benefits of the heat refuge rule come from deaths avoided. In the provisional figures from the Week 6 design, the performance standard avoids about 27 deaths a year at an annualized cost of about $130 million. Valued at a composite central value per statistical life of $12 million, those deaths are worth about $327 million and net benefits are clearly positive. If the same deaths are instead valued by the life-years they add, the picture changes. Residents protected by the rule have short expected survival: in a national cohort of nursing home decedents, half had died within about five months of placement (Kelly et al., 2010). Assuming each death avoided adds 1.4 years of life and valuing each year at about $520,000, which is the composite $12 million spread over the discounted remaining life of a 40-year-old at 3 percent, each death avoided is worth about $730,000. Benefits then fall to about $21 million and net benefits become negative by roughly $110 million. The method does not refine the answer; it reverses it. This paper examines both approaches and chooses between them.

What this page is doingShowing the reversal first justifies a full paper on what might look like a technical choice.
3

The Value per Statistical Life

The value per statistical life is not a price on any person's life. It is the sum of what many people would pay to lower their risk of death slightly, expressed per death avoided. If 10,000 people would each pay $1,200 to reduce their annual risk of death by 1 in 10,000, together they would pay $12 million to avoid one expected death. Federal agencies use the value to compare mortality risk reductions with costs, and HHS guidelines for regulatory impact analysis treat it as the standard measure for that purpose (Office of the Assistant Secretary for Planning and Evaluation, 2016).

The evidence behind the number comes mainly from two sources. Labor market studies estimate the wage premiums workers accept for jobs with higher fatal risk, and a large review of those studies found most estimates for US workers in a band of several million dollars (Viscusi & Aldy, 2003). Stated preference studies ask people directly what they would pay for risk reductions. Both draw largely on working-age adults. Workers choosing among jobs are healthy enough to work, decades younger than the residents this rule protects, whose mean age in recent nursing home studies is in the mid-80s (Katz et al., 2026). Applying the value to frail residents is therefore a transfer from one population to a very different one, and no direct study measures what frail nursing home residents would pay to reduce heat risk.

The Quality-Adjusted Life Year

This measure combines length and quality of life: a year of full health is scored 1, while a year in a state judged half as good is scored 0.5. QALYs are the usual outcome measure in cost-effectiveness analysis, which reports the cost per QALY gained rather than a net monetary benefit. They do not belong in cost-benefit analysis unless they are given a monetary value, and that conversion is itself contested. Hammitt (2002) shows that QALYs and willingness to pay rank health outcomes the same way only under restrictive assumptions about preferences, and that they answer different questions: QALYs ask how much health an intervention produces, while willingness to pay asks what that health is worth to those affected.

For this rule, QALYs make the frailty of the beneficiaries explicit. With 1.4 years of added life and a quality weight of 0.55, each death avoided yields about 0.77 QALYs. The performance standard would then gain about 21 QALYs a year at a net cost of about $6.2 million per QALY, far above any threshold commonly used in health technology assessment.

The Question of Age

Any attempt to adjust the value per statistical life for age meets strong objections. In the early 2000s a federal air quality analysis applied a lower value to deaths among people over 70, and public criticism of what was called a senior death discount led to its withdrawal. The empirical question is unsettled. Viscusi and Aldy (2007) found in labor market data that the value varies over the life cycle and declines for older workers, but their data end with working-age adults and say nothing directly about people in their 80s. Some economists argue that older people, with fewer years left, would pay less for risk reductions; others note that wealth and the value placed on remaining time may rise with age. The ethical objection is separate from the empirical one. Treating an 87-year-old's death as worth less than a 40-year-old's is a judgment many would reject regardless of what willingness-to-pay data show. This paper reports the controversy and does not adopt an age adjustment.

The Question of Disability

QALYs face a parallel objection. Because a year lived with impairment receives a quality weight below one, a treatment that extends the life of a person with a disability produces fewer QALYs than the same extension for a person without one. A federal disability council concluded that QALY-based analysis devalues the lives of people with disabilities and recommended against its use in federal health programs (National Council on Disability, 2019). Federal law already bars the Patient-Centered Outcomes Research Institute from developing or using a dollars-per-QALY threshold (42 U.S.C. § 1320e-1). Nearly all nursing home residents live with significant impairment, so this objection applies with full force here. A method that values their remaining time at roughly half of a year in full health builds a judgment about their lives into the calculation.

Choice and Its Costs

Table 1

Two Valuation Approaches Compared for the Heat Refuge Rule

FeatureUnadjusted value per statistical lifeQALY-based cost-effectiveness |
Value per death avoidedAbout $12 millionAbout 0.77 QALYs |
Result for performance standardNet benefits about $197 millionAbout $6.2 million per QALY |
Evidence baseWorking-age adultsHealth state preferences, often from general population surveys |
Main objectionIgnores short remaining life of residentsValues life with impairment at less than full health |

Figures are from the provisional Week 6 model and use composite values.

The main analysis will use an unadjusted value per statistical life, consistent with HHS guidelines. It treats a reduction in the risk of death as equally valuable regardless of age or impairment, which matches how the rule's protection is offered. A QALY-based cost-effectiveness ratio will be reported beside it as a secondary measure. Reporting both will show readers that the verdict depends on the valuation method, which they would not learn if only one were shown.

The choice has costs. The main analysis almost certainly overstates what is gained in years of life, and a reader who believes that remaining life expectancy should count will find the net benefit figure misleading. The secondary measure answers that reader without adopting an adjustment the main analysis rejects. Week 9 will add a life-year approach to the sensitivity analysis so that the reversal shown at the start of this paper is tested directly.

References

Hammitt, J. K. (2002). QALYs versus WTP. Risk Analysis, 22(5), 985-1001. https://doi.org/10.1111/1539-6924.00265

Katz, G. M., Brown, K. A., Giannakeas, V., & Stall, N. M. (2026). Air conditioning in nursing homes and mortality during extreme heat. JAMA Internal Medicine, 186(2), 243-251. https://doi.org/10.1001/jamainternmed.2025.6595

Kelly, A., Conell-Price, J., Covinsky, K., Cenzer, I. S., Chang, A., Boscardin, W. J., & Smith, A. K. (2010). Length of stay for older adults residing in nursing homes at the end of life. Journal of the American Geriatrics Society, 58(9), 1701-1706. https://doi.org/10.1111/j.1532-5415.2010.03005.x

Limitations on certain uses of comparative clinical effectiveness research, 42 U.S.C. § 1320e-1 (2018).

National Council on Disability. (2019). Quality-adjusted life years and the devaluation of life with disability.

Office of the Assistant Secretary for Planning and Evaluation. (2016). Guidelines for regulatory impact analysis. U.S. Department of Health and Human Services.

Viscusi, W. K., & Aldy, J. E. (2003). The value of a statistical life: A critical review of market estimates throughout the world. Journal of Risk and Uncertainty, 27(1), 5-76. https://doi.org/10.1023/A:1025598106257

Viscusi, W. K., & Aldy, J. E. (2007). Labor market estimates of the senior discount for the value of statistical life. Journal of Environmental Economics and Management, 53(3), 377-392. https://doi.org/10.1016/j.jeem.2006.10.005

What the HLTH 8451 Week 7 instructions ask for

Valuation critiques ask students to compare methods for valuing health outcomes in regulatory or economic analysis, usually the value per statistical life and quality-adjusted life years, and to choose one for their own analysis. Prompts typically ask for the evidence base of each method, the ethical controversies around age and disability, and a justified choice. Instructors expect the paper to show why the choice matters for the specific policy, ideally with numbers. Neither method should be spared criticism. Expect eight to ten pages. A comparison table is common but not always required. Prompts may also ask how the chosen method will be presented to a decision maker who is not an economist.

How the HLTH 8451 Week 7 example is put together

The paper opens by showing the reversal in numbers, using the Week 6 model. The statistical life section explains willingness to pay with a worked example and names the labor market and stated preference evidence. The QALY section explains the measure and why it belongs to cost-effectiveness analysis. An age section reports the senior discount episode and labor market findings without adopting an adjustment. A disability section applies the same scrutiny to QALYs, citing a federal council report and a statutory limit. A table compares the two approaches, and the conclusion adopts one and reports the other. The comparison table places the value per death, the result for the favored alternative, the evidence base and the main objection side by side for each method.

Reading the HLTH 8451 Week 7 rubric

Faculty reward papers that show the stakes for the specific policy before explaining the methods. Explaining the value per statistical life correctly, as aggregated willingness to pay for small risk reductions, avoids the most common error. Naming the gap between the evidence population and the policy population shows critical reading. Treating age and disability with equal rigor earns credit, as does keeping empirical and ethical objections separate. A conclusion that chooses one method and reports the other, explaining the cost of the choice, is usually what earns the top band. Using a worked example to explain the statistical life value helps readers who find the concept counterintuitive.

HLTH 8451 Week 7 help from the desk

Calculate your policy's benefits under both methods before writing, even roughly, so you know whether the choice matters. Then describe where each method's numbers come from and who was studied. Ask whether the people your policy protects resemble those people. Write separate paragraphs on empirical and ethical objections. Choose one method for your main analysis and decide how you will report the other. If the numbers or the ethics feel hard to balance in one paper, a custom sample critique on your own policy can show the order of argument. Read the age and disability critiques in their original sources rather than in summaries, since the details matter.

Get a HLTH 8451 Week 7 example written to your instructions

Send along the Week 7 prompt and rubric and the health outcomes your analysis must value. An HLTH 8451 critique comes back comparing valuation methods against your population and choosing one openly, within 24 to 48 hours; the first request carries no fee. Its residents and rule are composites, and it quotes no agency's dollar values.

More HLTH 8451 papers and doctoral health administration program samples

HLTH 8451 Week 7 questions, answered

Where can I find a free HLTH 8451 Week 7 sample paper?

The valuation critique comparing statistical life values and QALYs for the heat rule is on this page.

What is a value per statistical life?

The total that many people would pay for small reductions in their risk of death, expressed per expected death avoided.

Why does the choice reverse the verdict?

The residents protected have short expected survival, so a life-year approach values each death avoided far lower.

Does the paper adjust for age?

No. It reports the controversy and adopts an unadjusted value for the main analysis.

How are QALYs used?

As a secondary cost-effectiveness measure reported beside the main cost-benefit result.